Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck - Concepedia

Concepedia

Publication | Open Access

Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

DOI Full Paper Access

132

Citations

27

References

2021

Year

Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, Michael Rubin, Ying Yuan, Diana Bell, Adel K. El‐Naggar, Jason M. Johnson, William H. Morrison, David I. Rosenthal,

Clinical Cancer Research

Abstract

Neoadjuvant immunotherapy in locoregionally advanced, resectable CSCC-HN is safe and induces a high pathologic response rate. Pathologic responses were associated with an inflamed tumor microenvironment.

References

	Year	Citations

Page 1